Guardant Health Goes Beyond Cancer
Guardant Health was founded by Helmy Eltouhky, PHD and AmirAli Talasaz, PhD in 2013. In that time the Redwood City, CA-based company has mostly resided in the liquid biopsy space for the detection of cancer. However, Guardant, which once brought in about $3 in a financing round, changed gears a bit and developed a COVID-19 test. The firm recently won emergency use authorization for Guardant-19, a next-generation sequencing-based COVID-19 test. Executives from the publicly traded company said the test was developed out of civic duty and not as an additional business. They also added that they were strongly committed to developing oncology tests.